Celebrazioni 850 anni di Unimore - Towards a phaseI/II clinical trial for a hematopoietic stem cell gene editing platform to treat primary immunodeficiency diseases

Ciclo Seminari

«Terapie Cellulari e Geniche 2025»

Per gli 850 Anni di UniMoRe

Prof.ssa Alessia Cavazza

Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto - UniMoRe

Zayed Centre for Research into Rare Diseases in Children

University College London-Great Ormond Street

Institute of Child Health – Londra (UK)

Towards a phaseI/II clinical trial for a hematopoietic stem cell gene editing platform to treat primary immunodeficiency diseases